BEVACIZUMAB-ADCD: 83 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
83
Total FAERS Reports
15 (18.1%)
Deaths Reported
24
Hospitalizations
83
As Primary/Secondary Suspect
3
Life-Threatening
Prescription
Status
FDA Application: 761268 ·
First Report: 20171201 · Latest Report: 20250816
What Are the Most Common BEVACIZUMAB-ADCD Side Effects?
#1 Most Reported
Intentional product use issue
23 reports (27.7%)
#2 Most Reported
Neutropenia
10 reports (12.0%)
#3 Most Reported
Asthenia
8 reports (9.6%)
All BEVACIZUMAB-ADCD Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Intentional product use issue | 23 | 27.7% | 3 | 7 |
| Neutropenia | 10 | 12.1% | 3 | 1 |
| Asthenia | 8 | 9.6% | 4 | 1 |
| Drug ineffective | 7 | 8.4% | 0 | 0 |
| Decreased appetite | 6 | 7.2% | 3 | 2 |
| Diarrhoea | 6 | 7.2% | 4 | 1 |
| Thrombocytopenia | 6 | 7.2% | 3 | 1 |
| Vomiting | 6 | 7.2% | 1 | 2 |
Who Reports BEVACIZUMAB-ADCD Side Effects? Age & Gender Data
Gender: 56.7% female, 43.3% male. Average age: 64.3 years. Most reports from: KR. View detailed demographics →
Is BEVACIZUMAB-ADCD Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2017 | 1 | 0 | 1 |
| 2023 | 11 | 3 | 2 |
| 2024 | 38 | 3 | 16 |
| 2025 | 25 | 8 | 5 |
What Is BEVACIZUMAB-ADCD Used For?
Official FDA Label for BEVACIZUMAB-ADCD
Official prescribing information from the FDA-approved drug label.